BioCentury | Jul 11, 2020
Translation in Brief

Peptide blocker of myeloid checkpoint; plus a magnet-based device to collect circulating tumor cells, severe vs. mild COVID-19 immune cell profiles and more

...levels of T cell inhibitory molecules. ACE2 binding integrin as COVID-19 target in heart tissue University of Colorado Anschutz Medical Campus...
...Signal regulatory protein alpha TYRP1 - Tyrosinase related protein 1 Danielle Kopke, Staff Writer Massachusetts General Hospital University of Colorado Anschutz Medical Campus Arca...
BioCentury | May 31, 2019
Targets & Mechanisms

Targeting cancer evolution offers a way to foil drug resistance

...said James DeGregori, a professor of biochemistry and molecular genetics, molecular biology and immunology at University of Colorado Anschutz Medical Campus...
...Jolla, Calif. The Institute of Cancer Research, London, U.K. Thrive Earlier Detection Corp., Cambridge, Mass. University of Colorado Anschutz Medical Campus...
...Associate Editor Achilles Therapeutics Ltd. ApoGen Biotechnologies Inc. Cancer Research UK Dana-Farber Cancer Institute Francis Crick Institute The Institute of Cancer Research University of Colorado Anschutz Medical Campus University...
BioCentury | Jan 23, 2019
Distillery Therapeutics

Cardiovascular

...2018 doi:10.1073/pnas.1808618116 CONTACT: Kunhua Song, University of Colorado Auschutz Medical Campus, Aurora, Colo. email: kunhua.song@ucdenver.edu Michael Leviten University of Colorado Anschutz Medical Campus Lysosomal-associated...
BioCentury | Jan 16, 2019
Translation in Brief

Mighty microglia

...1 ligand 1; SIRPA (CD172a; SHPS-1) - Signal regulatory protein α Elizabeth S. Eaton, Staff Writer Stanford University University of Colorado Anschutz Medical Campus CD47 Programmed...
BioCentury | Dec 14, 2018
Financial News

Allen Insitute's immunology division launches with $125M, Lilly vet and five partners

...Benaroya Research Institute at Virginia Mason (BRI); the University of California San Diego and the University of Colorado Anschutz Medical Campus...
...Allen Institute, Seattle, Wash. Jennie Walters Allen Institute Benaroya Research Institute Fred Hutchinson Cancer Research Center University of California San Diego University of Colorado Anschutz Medical Campus University...
BioCentury | Dec 13, 2018
Preclinical News

Allen Institute's immunology division launches with $125M, Lilly vet and five partners

...Benaroya Research Institute at Virginia Mason (BRI); the University of California San Diego and the University of Colorado Anschutz Medical Campus...
...said during the briefing. Jennie Walters Allen Institute Benaroya Research Institute Fred Hutchinson Cancer Research Center University of California San Diego University of Colorado Anschutz Medical Campus University...
BioCentury | May 15, 2018
Distillery Techniques

Assays and screens; imaging

...published online May 1, 2018 doi:10.1038/s41467-018-03953-y CONTACT: Richard Benninger, University of Colorado Anschutz Medical Campus, Aurora, Colo. email: richard.benninger@ucdenver.edu Jaime De Leon University of Colorado Anschutz Medical Campus CD4 Diabetes...
BioCentury | Feb 13, 2018
Distillery Therapeutics

Cardiovascular

...published online Feb. 7, 2018 doi:10.1126/scitranslmed.aao0144 CONTACT: Timothy A. McKinsey, University of Colorado Anschutz Medical Campus, Aurora, Colo. email: timothy.mckinsey@ucdenver.edu Allison Johnson givinostat University of Colorado Anschutz Medical Campus HDAC...
BioCentury | Sep 1, 2017
Company News

IBM, JDRF pinpointing T1D risk factors with machine learning

...build predictive models. The first studies to be analyzed are the DAISY study by the University of Colorado Anschutz Medical Campus...
BioCentury | Aug 18, 2017
Company News

IBM, JDRF pinpointing T1D risk factors with machine learning

...build predictive models. The first studies to be analyzed are the DAISY study by the University of Colorado Anschutz Medical Campus...
Items per page:
1 - 10 of 13
BioCentury | Jul 11, 2020
Translation in Brief

Peptide blocker of myeloid checkpoint; plus a magnet-based device to collect circulating tumor cells, severe vs. mild COVID-19 immune cell profiles and more

...levels of T cell inhibitory molecules. ACE2 binding integrin as COVID-19 target in heart tissue University of Colorado Anschutz Medical Campus...
...Signal regulatory protein alpha TYRP1 - Tyrosinase related protein 1 Danielle Kopke, Staff Writer Massachusetts General Hospital University of Colorado Anschutz Medical Campus Arca...
BioCentury | May 31, 2019
Targets & Mechanisms

Targeting cancer evolution offers a way to foil drug resistance

...said James DeGregori, a professor of biochemistry and molecular genetics, molecular biology and immunology at University of Colorado Anschutz Medical Campus...
...Jolla, Calif. The Institute of Cancer Research, London, U.K. Thrive Earlier Detection Corp., Cambridge, Mass. University of Colorado Anschutz Medical Campus...
...Associate Editor Achilles Therapeutics Ltd. ApoGen Biotechnologies Inc. Cancer Research UK Dana-Farber Cancer Institute Francis Crick Institute The Institute of Cancer Research University of Colorado Anschutz Medical Campus University...
BioCentury | Jan 23, 2019
Distillery Therapeutics

Cardiovascular

...2018 doi:10.1073/pnas.1808618116 CONTACT: Kunhua Song, University of Colorado Auschutz Medical Campus, Aurora, Colo. email: kunhua.song@ucdenver.edu Michael Leviten University of Colorado Anschutz Medical Campus Lysosomal-associated...
BioCentury | Jan 16, 2019
Translation in Brief

Mighty microglia

...1 ligand 1; SIRPA (CD172a; SHPS-1) - Signal regulatory protein α Elizabeth S. Eaton, Staff Writer Stanford University University of Colorado Anschutz Medical Campus CD47 Programmed...
BioCentury | Dec 14, 2018
Financial News

Allen Insitute's immunology division launches with $125M, Lilly vet and five partners

...Benaroya Research Institute at Virginia Mason (BRI); the University of California San Diego and the University of Colorado Anschutz Medical Campus...
...Allen Institute, Seattle, Wash. Jennie Walters Allen Institute Benaroya Research Institute Fred Hutchinson Cancer Research Center University of California San Diego University of Colorado Anschutz Medical Campus University...
BioCentury | Dec 13, 2018
Preclinical News

Allen Institute's immunology division launches with $125M, Lilly vet and five partners

...Benaroya Research Institute at Virginia Mason (BRI); the University of California San Diego and the University of Colorado Anschutz Medical Campus...
...said during the briefing. Jennie Walters Allen Institute Benaroya Research Institute Fred Hutchinson Cancer Research Center University of California San Diego University of Colorado Anschutz Medical Campus University...
BioCentury | May 15, 2018
Distillery Techniques

Assays and screens; imaging

...published online May 1, 2018 doi:10.1038/s41467-018-03953-y CONTACT: Richard Benninger, University of Colorado Anschutz Medical Campus, Aurora, Colo. email: richard.benninger@ucdenver.edu Jaime De Leon University of Colorado Anschutz Medical Campus CD4 Diabetes...
BioCentury | Feb 13, 2018
Distillery Therapeutics

Cardiovascular

...published online Feb. 7, 2018 doi:10.1126/scitranslmed.aao0144 CONTACT: Timothy A. McKinsey, University of Colorado Anschutz Medical Campus, Aurora, Colo. email: timothy.mckinsey@ucdenver.edu Allison Johnson givinostat University of Colorado Anschutz Medical Campus HDAC...
BioCentury | Sep 1, 2017
Company News

IBM, JDRF pinpointing T1D risk factors with machine learning

...build predictive models. The first studies to be analyzed are the DAISY study by the University of Colorado Anschutz Medical Campus...
BioCentury | Aug 18, 2017
Company News

IBM, JDRF pinpointing T1D risk factors with machine learning

...build predictive models. The first studies to be analyzed are the DAISY study by the University of Colorado Anschutz Medical Campus...
Items per page:
1 - 10 of 13